articleTop 1% cited
Treatment of Chronic Posterior Laryngitis With Esomeprazole
The Laryngoscope · 2006 · Vol. 116(2) · pp. 254–260
Michael F. Vaezi✉(Temple University)Joel E. Richter(Temple University)C. Richard StasneyJoseph R. Spiegel(Thomas Jefferson University)Ralph A. Iannuzzi(University of Massachusetts Chan Medical School)Joseph A. CrawleyClara HwangMark SostekReza Shaker(Medical College of Wisconsin)
Abstract
This study provides no evidence of a therapeutic benefit of treatment with esomeprazole 40 mg twice daily for 16 weeks compared with placebo for signs and symptoms associated with CPL.
Gastroesophageal reflux and treatmentsRespiratory and Cough-Related ResearchVoice and Speech DisordersEsomeprazoleMedicineLaryngoscopyPlaceboProton-pump inhibitorLaryngitisSore throatInternal medicineClinical endpointReflux
MeSH terms
AdultAgedChronic DiseaseDouble-Blind MethodEnzyme InhibitorsFemaleGastroesophageal RefluxHumansLaryngitisMaleMiddle AgedProspective StudiesTreatment OutcomeProton Pump InhibitorsEsomeprazole
Funding
- AstraZeneca
Citations
333
FWCI
11.73
field-weighted impact
References
23
Percentile
99%
vs. same field & year
Citations per year
References
The Validity and Reliability of the Reflux Finding Score (RFS)
The Laryngoscope · 2001 · 1,058 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.